Ocuphire Pharma | DEF 14A: Definitive information statements
Apr 30 05:04
Ocuphire Pharma | ARS: Annual Report to Security Holders
Apr 30 04:51
Ocuphire Pharma | DEFA14A: Others
Apr 30 04:46
Ocuphire Pharma | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 20 05:30
Ocuphire Pharma | 8-K: Current report
Apr 18 04:26
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Director Pepose Jay
Apr 16 04:15
Ocuphire Pharma | 8-K: Current report
Mar 28 04:30
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Officer SCHACHLE JOSEPH K
Mar 26 04:50
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Jhaveri Nirav S.
Mar 26 04:44
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Magrath George
Mar 21 04:23
Ocuphire Pharma | 10-K: Annual report
Mar 9 06:26
Ocuphire Pharma | 8-K: Ocuphire Pharma Announces Financial Results for Fourth Quarter and Full Year 2023 and Provides Corporate Update
Mar 8 21:25
Ocuphire Pharma | 424B3: Prospectus
Feb 17 05:33
Ocuphire Pharma | 8-K: Current report
Feb 17 05:07
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Jhaveri Nirav S.
Feb 15 07:38
Ocuphire Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Jayagopal Ashwath
Feb 15 07:38
Ocuphire Pharma | 3: Initial statement of beneficial ownership of securities-Officer Jhaveri Nirav S.
Feb 15 07:38
Ocuphire Pharma | 3: Initial statement of beneficial ownership of securities-Officer Jayagopal Ashwath
Feb 15 07:33
Ocuphire Pharma | EFFECT: Others
Jan 24 19:04
Ocuphire Pharma | CORRESP: CORRESP
Jan 23 11:40
No Data
No Data